Pharma Deko Statistics
Total Valuation
Pharma Deko has a market cap or net worth of NGN 396.98 million. The enterprise value is 403.98 million.
| Market Cap | 396.98M |
| Enterprise Value | 403.98M |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharma Deko has 216.93 million shares outstanding.
| Current Share Class | 216.93M |
| Shares Outstanding | 216.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.36 |
| EV / Sales | 0.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.11 |
Financial Position
The company has a current ratio of 0.21, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.21 |
| Quick Ratio | 0.08 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.50 |
| Interest Coverage | -31.90 |
Financial Efficiency
Return on equity (ROE) is -25.54% and return on invested capital (ROIC) is -15.12%.
| Return on Equity (ROE) | -25.54% |
| Return on Assets (ROA) | -7.79% |
| Return on Invested Capital (ROIC) | -15.12% |
| Return on Capital Employed (ROCE) | -26.53% |
| Revenue Per Employee | 6.71M |
| Profits Per Employee | -4.23M |
| Employee Count | 70 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.22 |
Taxes
In the past 12 months, Pharma Deko has paid 2.49 million in taxes.
| Income Tax | 2.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.00 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.83 |
| 200-Day Moving Average | 1.83 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Deko had revenue of NGN 469.58 million and -296.19 million in losses. Loss per share was -2.73.
| Revenue | 469.58M |
| Gross Profit | 98.28M |
| Operating Income | -284.77M |
| Pretax Income | -293.70M |
| Net Income | -296.19M |
| EBITDA | -215.76M |
| EBIT | -284.77M |
| Loss Per Share | -2.73 |
Balance Sheet
The company has 9.79 million in cash and 16.78 million in debt, giving a net cash position of -6.99 million or -0.03 per share.
| Cash & Cash Equivalents | 9.79M |
| Total Debt | 16.78M |
| Net Cash | -6.99M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 4.66 |
| Working Capital | -918.91M |
Cash Flow
In the last 12 months, operating cash flow was -28.69 million and capital expenditures -4.66 million, giving a free cash flow of -33.36 million.
| Operating Cash Flow | -28.69M |
| Capital Expenditures | -4.66M |
| Free Cash Flow | -33.36M |
| FCF Per Share | -0.15 |
Margins
Gross margin is 20.93%, with operating and profit margins of -60.64% and -63.07%.
| Gross Margin | 20.93% |
| Operating Margin | -60.64% |
| Pretax Margin | -62.54% |
| Profit Margin | -63.07% |
| EBITDA Margin | -45.95% |
| EBIT Margin | -60.64% |
| FCF Margin | n/a |
Dividends & Yields
Pharma Deko does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -74.61% |
| FCF Yield | -8.40% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |